Search

AbstractGabapentin is an anticonvulsant that has an abuse potential. The aim of this study was to investigate the misuse and abuse of gabapentin in Jordan from the perspective of community pharmacists. A cross-sectional survey using a self-reported structured questionnaire was used with a convenience sample of pharmacists employed by various independent and chain community pharmacies. An online technique was used in this study using Google forms. A total of 215 questionnaires were completed, with 200 respondents (93%) reporting awareness of cases of gabapentin abuse in their pharmacies. Less than half of the respondents (n = 94; 43.7%) indicated that gabapentin requests were not accompanied by prescriptions. Almost two-thirds of respondents (63.6%) noticed an increased pattern of gabapentin abuse/misuse during the last 6 months. The study underscores the need for regulatory efforts and pharmacovigilance to manage potential gabapentin abuse, along with pharmacist and patient education at the community pharmacy, regarding potential abuse of gabapentin. [ABSTRACT FROM AUTHOR]

This study was conducted to provide background regarding knowledge, attitude, and practice (KAP) of ophthalmologists in Jordan regarding ophthalmic product abuse and misuse. A cross-sectional self-reported survey was conducted among a sample of ophthalmologists of all ranks who were working at different hospitals, centers, and clinics in Jordan. A total of 137 valid questionnaires were returned (response rate = 69.1%). The majority of respondents were male (73.7%) and between 20 and 40 years old. Only 47.4% of our sample knew the correct difference between the definitions "abuse" and "misuse." The majority of participating ophthalmologists (87.6%) reported that ophthalmic drugs were liable to abuse. Ophthalmologists 40 years or younger had more knowledge about ophthalmic products abuse than their older counterparts (p < 0.05). Most ophthalmologists (67.2%) reported Pentolate® eye drop (cyclopentolate) as the top ophthalmic product liable to abuse. This study provided, for the first time, background regarding the knowledge, attitude, and practice of ophthalmologists about this relatively uncommon and alerting type of drug abuse. Moreover, it highlighted the importance of increasing awareness of ophthalmologists and community pharmacists who dispense such drugs about the issue. [ABSTRACT FROM AUTHOR]

The occupied Palestinian territories (oPt) consist of the non-contiguous West Bank including East Jerusalem and the Gaza Strip. It is densely populated within these confines and has a unique socio-economic context characterized by political and economic tensions. Around 2.2 million Palestinians are displaced and living in the ten UNRWA refugee camps in Jordan. Palestinian communities are exposed to a double burden of disease caused by the severe economic, social and health consequences of Israeli occupation and resultant displacement. Exposure to political violence, economic hardship, fragmentation of Palestinian families, unemployment, trauma and community stress underpin a reported rise in drug abuse. Method: A qualitative study using focus groups (n = 3) with a convenience sample of health care and educational professionals was conducted in two UNRWA camps (Al-Zarka, Al-Wehdat) in Jordan. Guided discussions explored the experiences of these professionals in working with Palestinian families and children affected by substance/drug use and drug use disorder in the home. Data were analysed using thematic analysis (TA). Five themes emerged from the TA. These were as follows: (1) access to drugs was perceived to be relatively easy in the camps; (2) Attitudes towards drugs appear to have desensitized, yet stigma persists; (3) families of drug users are affected by fear, social and economic poverty, with significant physical and psychological cost to children; (4) causes of substance/drug use in Palestinian communities living in Jordanian UNRWA camps is multifactorial; (5) solutions are multi-faceted and indicative of the need for prevention and support for those at risk, and affected. Threats to UNRWA from the current political climate and the reducing investment in services may exacerbate this public health and security issue. For an evidence-based approach to have credibility in the camp communities, there is a need for accurate, factual information, along with robust epidemiological data, relating to the extent, characteristics and harms associated with drug use. [ABSTRACT FROM AUTHOR]

Pregabalin is an anticonvulsant that has an abuse potential. The aim of this study was to investigate abuse/misuse of pregabalin in Jordan from the perspective of community pharmacists. A cross-sectional survey using a structured questionnaire was delivered to a sample of community pharmacies. Self-reported method was used to fill the surveys. A total of 151/205 questionnaires were completed (response rate = 74.1%). A total of 132 respondents (87.4%) reported cases of pregabalin abuse in their pharmacies. Less than half of the respondents (n = 69; 45.7%) indicated that pregabalin requests were, in most of the cases, not accompanied by prescriptions. More than half of the sample (55.8%) noticed an increased pattern of pregabalin abuse/misuse during the last 6 months. The study underscored the need for regulatory efforts and pharmacovigilance to manage pregabalin abuse, along with a pharmacist and patient education at a community pharmacy level. [ABSTRACT FROM AUTHOR]

Background: There has been a trend in the past five years in Jordan for ophthalmic anticholinergic preparations to be misused or abused. This is done mainly to experience mental altering effects such as mood changes, euphoria or hallucinations. Such products are mostly obtained from community pharmacies without a prescription., Objectives: This study aimed to observe the requests of ophthalmic preparations in community pharmacies in Amman, Jordan, and evaluating the most popular and frequently requested ophthalmic drops suspected of abuse. Also, it aimed to describe the current methods that Jordanian community pharmacists use to manage such requests., Methods: A prospective cross-sectional observational study was conducted between November 2016 and January 2017 at sixteen different community pharmacies in Amman. All ophthalmic products requested were observed during this period., Results: A total of 140 ophthalmic product requests for 130 customers were observed. Dry eye was the most common complaint for which the customer requested the medication (n = 30, 23.1%) and direct self-medication (ie-requesting the product by name), was the most frequent method of purchase (n = 63, 48.5%). In 19 cases (14.6%), product requests were suspected to be for non-medical (ie-abuse) purposes. Most of the suspected cases were for Pentolate ® (n = 11, 57.9%), whereas 7 were for Prisoline ® (36.8%) and 1 for Naphcon-A ® (5.3%). The majority of observed cases were for products requested without a prescription (n = 16, 84.2%), and in 12 cases out of which, sale was refused (63.2%)., Conclusion: More effort and enforcement of pharmacy regulation for safe dispensing is needed to reduce the abuse of ophthalmic products. Educating pharmacists and ophthalmologists would help raise awareness and control the type of drug abuse., (Copyright © 2019 Elsevier Inc. All rights reserved.)